Skip to main content
. 2023 Feb 22;24(5):4351. doi: 10.3390/ijms24054351

Figure 4.

Figure 4

Figure 4

Forest plot demonstrating the effect of umbilical cord blood-derived cell therapy on neuroinflammation (A) TNF-α; (B) IL-6; (C) IL-1β; (D) IL-10. Umbilical cord blood-derived cell therapy significantly decreased neuroinflammation as measured by TNF-α (p < 0.0001), IL-6 (p < 0.01) and IL-1β (p = 0.001). Abbreviations: admin, administration; ICV, intracerebroventricular; IV, intravenous; PCB, preterm cord blood; TCB, term cord blood; UCBC, umbilical cord blood cells.